650nm Low-level Red-light for Myopia Control and Prevention in Children
NCT ID: NCT05786586
Last Updated: 2024-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
572 participants
INTERVENTIONAL
2023-03-26
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Real-world Study of 650nm Low-intensity Single-wavelength Red Light for Children and Adolescents
NCT05832723
Effects of Low-Level Red Light and Distant-Image Screen for Myopia Control in Children
NCT06683287
Red Light Intervention for Myopia Prevention
NCT04825769
Effect of Low-level Red-light on Ultra-high Myopia
NCT06738095
Clinical Study of Light Therapy to Control Myopia Progression in Children
NCT05761379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
650 nm low-level red-light, plus single vision spectacle lenses
Children in the treatment group are expected to receive 6 minutes irradiation of 650 nm low-level red-light daily, divided into two times a day, each lasting for 3 minutes. Single vision spectacle lenses are allowed for myopic children.
650 nm low-level red-light
650 nm low-level red-light is a kind of laser, concentrated into a beam, to repeatedly irradiate the retina
Control
Single vision spectacle lenses are allowed for myopic children. No intervention was given.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
650 nm low-level red-light
650 nm low-level red-light is a kind of laser, concentrated into a beam, to repeatedly irradiate the retina
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The cycloplegic spherical equivalent error (SER) is -6D to 1D (\> -6D, ≤1D) in both eyes
* Astigmatism of 2.5 D or less (≤2.5D)
* Willing to participate in the study and sign the informed consent form
Exclusion Criteria
* With anisometropia (difference in sphere between two eyes was 1.5D or greater), strabismus, or amblyopia
* With refractive media opacification (keratopathy, lens opacity, etc.)
* Allergy to cycloplegia drugs
6 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Children's Hospital
OTHER
Children's Hospital of The Capital Institute of Pediatrics
OTHER
Beijing Tongren Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ying Jie, MD
Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ying Jie
Role: PRINCIPAL_INVESTIGATOR
Beijing Tongren Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tongren Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TongrenJY2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.